Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer

Abstract

Loss of the tumor suppressive effect of transforming growth factor-β (TGF-β) has been commonly found at later stages in carcinogenic progression. Although the genes encoding TGF-β receptors and Smads have been found genetically altered in certain human cancers, no mutation in Smad3 has been observed. Therefore, suppression of Smad3 expression may mediate key oncogenic properties of TGF-β. First, we observed that 37.5% of human gastric cancer tissues showed low to undetectable levels of Smad3 and that in nine human gastric cancer cell lines examined, two showed deficient Smad3 expression. Introduction of Smad3 into human gastric cancer cells that did not express Smad3, restored TGF-β responsiveness: induction of p21 and p15 gene expression, and growth inhibition in response to TGF-β. Furthermore, these Smad3-expressing cells showed markedly decreased and delayed tumorigenicity in vivo. These findings suggest that Smad3 expression may have a critical role in tumor suppression in the early stages of gastric carcinogenesis.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K and Kawabata M . (1999). J. Biol. Chem., 274, 35269–35277.

    Article  CAS  Google Scholar 

  • Birchmeier W and Behrens J . (1994). Biochim. Biophys. Acta, 1198, 11–26.

  • Blobe GC, Schiemann WP and Lodish HF . (2000). N. Engl. J. Med., 342, 1350–1358.

  • Bouck N, Stellmach V and Hsu SC . (1996). Adv. Cancer Res., 69, 135–174.

  • Calonge MJ and Massagué J . (1999). J. Biol. Chem., 274, 33637–33643.

    Article  CAS  Google Scholar 

  • Chang J, Park K, Bang YJ, Kim WS, Kim D and Kim S-J . (1997). Cancer Res., 57, 2856–2859.

  • Christofori G and Semb H . (1999). Trends Biochem. Sci., 24, 73–76.

  • Dameron KM, Volpert OV, Tainsky MA and Bouck N . (1994). Science, 265, 1582–1584.

    Article  CAS  Google Scholar 

  • Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y and Wang X-F . (1999). Mol. Cell. Biol., 19, 2495–2504.

    Article  CAS  Google Scholar 

  • de Caestecker MP, Piek E and Roberts AB . (2000). J. Natl. Cancer Inst., 92, 1388–1402.

  • Derynck R, Zhang Y and Feng XH . (1998). Cell, 95, 737–740.

    Article  CAS  Google Scholar 

  • Derynck R, Akhurst RJ and Balmain A . (2001). Nat. Genet., 29, 117–129.

  • Fearon ER and Vogelstein B . (1990). Cell, 61, 759–767.

    Article  CAS  Google Scholar 

  • Fink SP, Swinler SE, Lutterbaugh JD, Massagué J, Thiagalingam S, Kinzler KW, Vogelstein B, Willson JK and Markowitz S . (2001). Cancer Res., 61, 256–260.

  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W . (1991). J. Cell. Biol., 113, 173–185.

  • Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE . (1998). Nature, 392, 402–405.

    Article  CAS  Google Scholar 

  • Hahm K-B, Cho K, Lee C, Im Y-H, Choi S-G, Sorensen PHB, Thiele CJ and Kim S-J . (1999). Nat. Genet., 23, 222–227.

  • Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE . (1996). Science, 271, 350–353.

    Article  CAS  Google Scholar 

  • Hanahan D and Folkman J . (1996). Cell, 86, 353–364.

    Article  CAS  Google Scholar 

  • Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K and Ito Y . (1999). J. Biol. Chem., 274, 31577–31582.

    Article  CAS  Google Scholar 

  • Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S, Sato K and Hamada K . (1999). Cancer Res., 59, 3783–3789.

  • Heldin CH, Miyazono K and ten Dijke P . (1997). Nature, 390, 465–471.

    Article  CAS  Google Scholar 

  • Hirohashi S . (1998). Am. J. Pathol., 153, 333–339.

  • Ito Y and Miyazono K . (2003). Curr. Opin. Genet. Dev., 13, 43–47.

  • Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK and Bang YJ . (2002). Biochem. Biophys. Res. Commun., 292, 383–389.

  • Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK and Kim S-J . (1999). Br. J. Cancer, 80, 1144–1149.

  • Keller G . (2002). Pathologica, 94, 229–233.

    Article  CAS  Google Scholar 

  • Kieser A, Weich HA, Brandner G, Marme D and Kolch W . (1994). Oncogene, 9, 963–969.

  • Kim S-J, Im Y-H, Markowitz SD and Bang Y-J . (2000). Cytokine Growth Factor Rev., 11, 159–168.

  • Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, Chiba S, Yazaki Y, Matsumoto K and Hirai H . (1998). Nature, 394, 92–96.

    Article  Google Scholar 

  • Lee DK, Kim BC, Brady JN, Jeang KT and Kim S-J . (2002a). J. Biol. Chem., 277, 33766–33775.

    Article  CAS  Google Scholar 

  • Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ and Kim S-J . (2002b). J. Biol. Chem., 277, 38557–38564.

    Article  CAS  Google Scholar 

  • Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y . (2000). Cell, 109, 113–124.

  • Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S and Zhou Q . (1999). Genes Dev., 13, 2196–2206.

  • Markowitz S, Wang J, Meyeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV . (1995). Science, 268, 1336–1338.

    Article  CAS  Google Scholar 

  • Massagué J . (1998). Annu. Rev. Biochem., 67, 753–791.

    Article  Google Scholar 

  • Massagué J and Chen YG . (2000). Genes Dev., 14, 627–644.

  • Massagué J and Wotton D . (2000). EMBO J., 19, 1745–1754.

  • Moses HL and Serra R . (1996). Curr. Opin. Genet. Dev., 6, 581–586.

  • Mukhopadhyay D, Tsiokas L and Sukhatme VP . (1995). Cancer Res., 55, 6161–6165.

  • Müller N, Reinacher-Schick A, Baldus S, van Hengel J, Berx G, Baar A, van Roy F, Schmiegel W and Schwarte-Waldhoff I . (2002). Oncogene, 21, 6049–6058.

    Article  Google Scholar 

  • Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee HY, Park J-G, Lynch HT, Roberts AB, Vogelstein B and Markowitz SD . (1995). Cancer Res., 55, 5545–5547.

  • Park K, Kim S-J, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB . (1994). Proc. Natl. Acad. Sci. USA, 91, 8772–8776.

  • Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP and Roberts AB . (2001). J. Biol. Chem., 276, 19945–19953.

    Article  CAS  Google Scholar 

  • Powell SM, Harper JC, Hamilton SR, Robinson CR and Cummings OW . (1997). Cancer Res., 57, 4221–4224.

  • Riggins GJ, Kinzler KW, Vogelstein B and Thiagalingam S . (1997). Cancer Res., 57, 2578–2580.

  • Roberts AB and Sporn MB . 1990. Peptide Growth Factors and their Receptors, Sporn MB and Roberts AB ( eds ). Spinger-Verlag: Heidelberg, Germany, pp. 419–472.

    Book  Google Scholar 

  • Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Luttges J, Kloppel G, Graeven U, Eilert-Micus C, Hintelmann A and Schmiegel W . (2000). Proc. Natl. Acad. Sci. USA, 97, 9624–9629.

  • Schutte M . (1999). Ann. Oncol., 4 (Suppl.), 56–59.

  • Shattuck T.M, Costa J, Bernstein M, Jensen RT, Chung DC and Arnold A . (2002). J. Clin. Endocrinol. Metab., 87, 3911–3914.

  • Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Kuwano H, Nagamachi Y and Tahara E . (1999). Jpn. J. Clin. Oncol., 29, 3–7.

  • Sood R, Talwar-Trikha A, Chakrabarti SR and Nucifora G . (1999). Leukemia, 13, 348–357.

    Article  CAS  Google Scholar 

  • Takagi Y, Koumura H, Futamura M, Aoki S, Ymaguchi K, Kida H, Tanemura H, Shimokawa K and Saji S . (1998). Br. J. Cancer, 78, 1152–1155.

  • Takenoshita S, Tani M, Mogi A, Nagashima M, Nagamachi Y, Bennett WP, Hagiwara K, Harris CC and Yokota J . (1998). Carcinogenesis, 19, 803–807.

    Article  CAS  Google Scholar 

  • Vleminckx K, Vakaet Jr L, Mareel M, Fiers W and van Roy F . (1991). Cell, 66, 107–119.

    Article  CAS  Google Scholar 

  • Wakefield LM and Roberts AB . (2002). Curr. Opin. Genet. Dev., 12, 22–29.

  • Wall NA and Hogan BL . (1994). Curr. Opin. Genet. Dev., 4, 517–522.

  • Weinstein M, Monga SP, Liu Y, Brodie SG, Tang Y, Li C, Mishra L and Deng CX . (2001). Mol. Cell. Biol., 21, 5122–51231.

  • Xiangming C, Natsugoe S, Takao S, Hokita S, Ishigami S, Tanabe G, Baba M, Kuroshima K and Aikou T . (2001). Clin. Cancer Res., 7, 277–282.

  • Yanagisawa K, Uchida K, Nagatake M, Masuda A, Sugiyama M, Saito T, Yamaki K, Takahashi T and Osada H . (2000). Oncogene, 19, 2305–2311.

    Article  CAS  Google Scholar 

  • Yang H-K, Kang SH, Kim Y-S, Won K, Bang Y-J and Kim S-J . (1999). Oncogene, 18, 2213–2219.

    Article  CAS  Google Scholar 

  • Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB and Deng CX . (1999). EMBO J., 18, 1280–1291.

  • Zawel L, Daim JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B and Kern SE . (1998). Mol. Cell, 1, 611–617.

  • Zhu Y, Richardson JA, Parada LF and Graff JM . (1998). Cell, 94, 703–714.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A Roberts for critical reading of the manuscript, M Lewis for the preparation of the manuscript, K Miyazono for Smad3 construct, J Massagué for 3TP-Lux reporter, and S Kern for SBE-luc reporter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seong-Jin Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, SU., Kim, HT., Seong, D. et al. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23, 1333–1341 (2004). https://doi.org/10.1038/sj.onc.1207259

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207259

Keywords

This article is cited by

Search

Quick links